New Year’s Day price hikes on block­buster drugs set the stage for a big de­bate

Al­ler­gan, Pfiz­er, Bris­tol-My­ers Squibb, Bio­gen and oth­er top drug­mak­ers all cel­e­brat­ed the New Year’s with a tra­di­tion­al boost in the price of their top drugs. 

For Al­ler­gan, there was an across-the-board hike of 9.5% for 7 of its top 10 prod­ucts. Bio­gen’s Tec­fidera went up 6%, ac­cord­ing to a ros­ter of new drug prices as­sem­bled Jan­u­ary 1 by Umer Raf­fat from Ever­core ISI. Jar­diance and Trad­jen­ta at Eli Lil­ly went up 6% — af­ter they trig­gered a 2% hike for Al­im­ta just be­fore New Year’s. And so on….

Endpoints Premium

This article is for premium subscribers only

Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.